BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a...

Related Keywords

China ,Italy ,Boston ,Massachusetts ,United States ,Japan ,Canada ,London ,City Of ,United Kingdom ,Italian ,America ,Chinese ,Japanese ,Lauren Tengler ,Mike Mahoney ,Kate Haranis ,Boston Scientific Corporation ,Boston Scientific ,Nasdaq ,Exchange Commission ,Specialty Pharmaceuticals ,Prnewswire Boston Scientific Corporation ,Japanese Pharmaceuticals ,Apollo Endosurgery Inc ,Securities Exchange ,Devices Agency ,Acotec Scientific Holdings ,Scientific Corporation ,Middle East ,Latin America ,Medical Devices Agency ,Drug Coated Balloon ,Left Atrial Appendage Closure Device ,Wavewriter Spinal Cord Stimulator Systems ,Non Surgical Back ,Virgin Back ,Conventional Medical Management ,Aortic Valve ,Market Clinical Follow Up ,Aortic Valve System ,Interventional Advances ,Apollo Endosurgery ,Acotec Scientific Holdings Limited ,Rhythm Management ,Interventional Cardiology ,Emerging Markets ,Quarter Net Sales ,Year Net Sales ,Full Year ,First Quarter ,Statement Regarding Forward Looking Statements ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Quarterly Reports ,Months Ended December ,Mandatory Convertible Preferred Stock ,Ended December ,Before Income ,Estimated Annual Effective Tax Rate ,Financial Condition ,Quarterly Report ,